AbbVie will buy Aliada Therapeutics for US$1.4 billion in cash, it said on Monday (Oct 28), gaining access to the privately ...

Irritability is a common symptom of bipolar disorder, but how can you manage it when it strains your relationships with ...

Failed to import article template. Reason: Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app ...

AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric ...

For women with bipolar, menopause can bring extra challenges. Here’s what to know and how to manage both during this life ...

Alto Neuroscience, Inc. ("Alto") , a clinical stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that the Phase 2b ...

Two doses of psilocybin, the active ingredient in “magic mushrooms,” against a six-week course of the popular antidepressant ...

Light therapy not only aids winter doldrums, but can help depression, PMS, anxiety, and even bipolar disorder. Don’t knock it ...